Face Name Associative Memory Exam and biomarker status in the ARMADA study: Advancing reliable measurement in Alzheimer's disease and cognitive aging.

MLA

Rentz, Dorene M., et al. “Face Name Associative Memory Exam and Biomarker Status in the ARMADA Study: Advancing Reliable Measurement in Alzheimer’s Disease and Cognitive Aging.” Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, vol. 15, no. 3, July 2023, pp. 1–12. EBSCOhost, https://doi.org/10.1002/dad2.12473.

APA

Rentz, D. M., Klinger, H. M., Samaroo, A., Fitzpatrick, C., Schneider, O. R., Amagai, S., & Peipert, J. D. (2023). Face Name Associative Memory Exam and biomarker status in the ARMADA study: Advancing reliable measurement in Alzheimer’s disease and cognitive aging. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, 15(3), 1–12. https://doi.org/10.1002/dad2.12473

Chicago

Rentz, Dorene M., Hannah M. Klinger, Aubryn Samaroo, Colleen Fitzpatrick, Olivia R. Schneider, Saki Amagai, and John Devin Peipert. 2023. “Face Name Associative Memory Exam and Biomarker Status in the ARMADA Study: Advancing Reliable Measurement in Alzheimer’s Disease and Cognitive Aging.” Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring 15 (3): 1–12. doi:10.1002/dad2.12473.